Dimethicone+Pronase
PreclinicalProtein / enzyme
Dimethicone+Pronase is one of 6 small molecule programs targeting Premedication. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Premedication
#DrugCompanyPhaseTrials
1Duragesic
CCephalon
Approved
Ketalar
AAultman Health Foundation
Approved
Robinul
Jazz PharmaceuticalsPreclinical
Brufen
Boehringer IngelheimPreclinical
Dimethicone+Pronase
CChanghai Hospital
Preclinical
No Premedication
YYonsei University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Premedication1 trial
Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
Recruiting·—·N/A·NCT06713421·3,000 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dimethicone+Pronase. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Protein / enzyme[2]
- Highest Phase
- Preclinical[1]
- Company
- CChanghai Hospital